Dynamics of MMP-9, MMP-2 and TIMP-1 in a rat model of brain injury combined with traumatic heterotopic ossification

Molecular Medicine Reports

Volumn 15, Issue 4, 2017, Pages 2129-2135

  Shi, Wei Zhe ^a,b   Ju, Jin Yong ^c   Xiao, Hai Jun ^a   Xue, Feng ^d   Wu, Jiang ^e   Pan, Ming Mang ^a   Ni, Wei Feng ^d  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b Guangzhou Huadu District People's Hospital   (China)

^c JINZHOU MEDICAL UNIVERSITY   (China)

^d Shanghai Fengxian District Central Hospital   (China)

^e Department of Orthopaedics   (China)

Author keywords

Brain injury; Heterotopic ossification; Matrix metalloproteinase 2; Matrix metalloproteinase 9; Tissue inhibitor of metalloproteinase 1

Indexed keywords

EOSIN; GELATINASE A; GELATINASE B; HEMATOXYLIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ACHILLES TENDON RUPTURE; ANATOMY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIFICATION; CONTROLLED STUDY; DEGRADATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HETEROTOPIC OSSIFICATION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATORY CELL; LOWER LIMB; MALE; MOLECULAR PATHOLOGY; NONHUMAN; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RADIOGRAPHY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRAUMATIC BRAIN INJURY; ANIMAL; BRAIN; BRAIN INJURY; COMPLICATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BRAIN; BRAIN INJURIES; GENE EXPRESSION REGULATION; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; OSSIFICATION, HETEROTOPIC; RATS; RATS, SPRAGUE-DAWLEY; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 85015646368     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2017.6275     Document Type: Article

References (27)

1. Chen HC, Yang JY, Chuang SS, Huang CY and Yang SY: Heterotopic ossification in burns: Our experience and literature reviews. Burns 35: 857-862, 2009.
2. Reznik JE, Biros E, Marshall R, Jelbart M, Milanese S, Gordon S and Galea MP: Prevalence and risk-factors of neurogenic heterotopic ossification in traumatic spinal cord and traumatic brain injured patients admitted to specialised units in Australia. J Musculoskelet Neuronal Interact 14: 19-28, 2014.
3. Naraghi FF, DeCoster TA, Moneim MS, Miller RA and Rivero D: Heterotopic ossification. Orthopedics 19: 145-151, 1996.
4. Evans EB: Heterotopic bone formation in thermal burns. Clin Orthop Relat Res: 94-101, 1991.
5. Rodenberg E, Azhdarinia A, Lazard ZW, Hall M, Kwon SK, Wilganowski N, Salisbury EA, Merched-Sauvage M, Olmsted-Davis EA, Sevick-Muraca EM and Davis AR: Matrix metalloproteinase-9 is a diagnostic marker of heterotopic ossification in a murine model. Tissue Eng Part A 17: 2487-2496, 2011.
6. Oliveira CO, Ikuta N and Regner A: Outcome biomarkers following severe traumatic brain injury. Rev Bras Ter Intensiva 20: 411-421, 2008.
7. Feeney DM, Boyeson MG, Linn RT, Murray HM and Dail WG: Responses to cortical injury: I. Methodology and local effects of contusions in the rat. Brain Res 211: 67-77, 1981.
8. Nolan T, Hands RE and Bustin SA: Quantification of mRNA using real-time RT-PCR. Nat Protoc 1: 1559-1582, 2006.
9. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Methods 25: 402-408. 2001.
10. Lomnitski L, Kohen R, Chen Y, Shohami E, Trembovler V, Vogel T and Michaelson DM: Reduced levels of antioxidants in brains of apolipoprotein E-deficient mice following closed head injury. Pharmacol Biochem Behav 56: 669-673, 1997.
11. Lin L, Shen Q, Xue T, Duan X, Fu X and Yu C: Sonic hedgehog improves redifferentiation of dedifferentiated chondrocytes for articular cartilage repair. PloS One 9: e88550, 2014.
12. Xu JC, Wu T, Wu GH, Zhong ZM, Tang YZ and Chen JT: Leptin expression by heterotopic ossification-isolated tissue in rats with Achilles' tenotomy Saudi Med J 30: 605-610, 2009.
13. Hong CC and Yu PB: Applications of small molecule BMP inhibitors in physiology and disease. Cytokine Growth Factor Rev 20: 409-418, 2009.
14. Gupta K, Shukla M, Cowland JB, Malemud CJ and Haqqi TM: Neutrophil gelatinase-associated lipocalin is expressed in osteo-arthritis and forms a complex with matrix metalloproteinase 9. Arthritis Rheum 56: 3326-3335, 2007.
15. Hill PA, Murphy G, Docherty AJ, Hembry RM, Millican TA, Reynolds JJ and Meikle MC: The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts. J Cell Sci 107: 3055-3064, 1994.
16. Baker AH, Zaltsman AB, George SJ and Newby AC: Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation and death in vitro. TIMP-3 promotes apoptosis. J Clin Invest 101: 1478-1487, 1998.
17. Bohmer AE, Oses JP, Schmidt AP, Peron CS, Krebs CL, Oppitz PP, DAvila TT, Souza DO, Portela LV and Stefani MA: Neuron-specific enolase, S100B and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury. Neurosurgery 68: 1624-1631, 2011.
18. Dimopoulou I, Korfias S, Dafni U, Anthi A, Psachoulia C, Jullien G, Sakas DE and Roussos C: Protein S-100b serum levels in trauma-induced brain death. Neurology 60: 947-951, 2003.
19. Wang X, Mori T, Jung JC, Fini ME and Lo EH: Secretion of matrix metalloproteinase-2 and -9 after mechanical trauma injury in rat cortical cultures and involvement of MAP kinase. J Neurotrauma 19: 615-625, 2002.
20. Caron A, Desrosiers RR, Langlois S and Beliveau R: Ischemia-reperfusion injury stimulates gelatinase expression and activity in kidney glomeruli. Can J Physiol Pharmacol 83: 287-300, 2005.
21. Nagase H, Visse R and Murphy G: Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69: 562-573, 2006.
22. Sternlicht MD and Werb Z: How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17: 463-516, 2001.
23. Hess K, Ushmorov A, Fiedler J, Brenner RE and Wirth T: TNFalpha promotes osteogenic differentiation of human mesenchymal stem cells by triggering the NF-kappaB signaling pathway. Bone 45: 367-376, 2009.
24. Ortega N, Wang K, Ferrara N, Werb Z and Vu TH: Complementary interplay between matrix metalloproteinase-9, vascular endothe-lial growth factor and osteoclast function drives endochondral bone formation. Dis Model Mech 3: 224-235, 2010.
25. Kaplan FS, Glaser DL, Hebela N and Shore EM: Heterotopic ossification. J Am Acad Orthop Surg 12: 116-125, 2004.
26. Chakraborti S, Mandal M, Das S, Mandal A and Chakraborti T: Regulation of matrix metalloproteinases: An overview. Mol Cell Biochem 253: 269-285, 2003.
27. Li DQ, Lokeshwar BL, Solomon A, Monroy D, Ji Z and Pflugfelder SC: Regulation of MMP-9 production by human corneal epithelial cells. Exp Eye Res 73: 449-459, 2001.